Research
Energy balance
The safety of retatrutide needs to be determined in larger and longer trials.
Practitioners should be aware that more extensive safety data is needed before fully endorsing retatrutide.
StrongSupportsmedium confidence
The safety of retatrutide needs to be determined in larger and longer trials.
Why this rating
Based on the phase 1b clinical trial design mentioned in the abstract.
Source
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity?
Sheila A Doggrell · Expert Opinion on Investigational Drugs · 2023
DOI 10.1080/13543784.2023.2206560
otherCited 30×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →